Kathryn Newland is the Global Compliance & Records Management Lead with Regulatory Strategy and Compliance in Drug Safety Research & Development at Pfizer, Inc. Her responsibilities include leadership and management of the combined Compliance & Records Management organization, setting strategic direction for compliance and global archive and records management functions, assuring compliance with regulatory requirements, developing, implementing and managing processes, and managing budget and spending. She is also responsible for oversight of Contract Research Organization and Service Providers involved in the records management processes and management of non-clinical records for acquisition, collaboration and divestiture projects. Prior to joining Drug Safety R&D in 2008, she spent more than 20 years working in various aspects of quality assurance oversight for non-clinical studies and the regulatory environment supporting human health pharmaceutical, animal health pharmaceutical and environmental studies.
Ms. Newland is an active member of the Society of Quality Assurance, a member of the Scientific Archiving Specialty Section, of the GLP Specialty Section, and of the SQA Annual Meeting Program Committee. In addition, she is a member of the Mid-West Regional Chapter of the Society of Quality Assurance and of the National Capitol Area Regional Society of Quality Assurance. Ms. Newland has a Bachelor of Arts in Molecular, Cellular and Developmental Biology and a Master of Science in Quality Assurance & Regulatory Affairs.